There is a newer version of the record available.

Published May 22, 2023 | Version 1.0
Dataset Open

CGM Scoping Review Data Repository

Authors/Creators

  • 1. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C. United States
  • 2. School of Nutritional Sciences and Wellness, College of Agriculture and Life Sciences, University of Arizona, Tucson, A.Z., United States
  • 3. Arizona Health Sciences Library, Tucson, A.Z., United States
  • 4. Department of Kinesiology, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, T.X., United States

Description

This dataset represents the data extracted as part of a CGM-based biological feedback scoping review.

Files

Files (38.2 kB)

Name Size Download all
md5:f784eec6a3ff09195c1c49fb98381f58
38.2 kB Download

Additional details

References

  • Alfadhli E, Osman E, Basri T. Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetol Metab Syndr 2016; 8: 48.
  • Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial. Diabetes Res Clin Pract 2008; 80: 371–9.
  • Allen N, Whittemore R, Melkus G. A continuous glucose monitoring and problem-solving intervention to change physical activity behavior in women with type 2 diabetes: a pilot study. Diabetes Technol Ther 2011; 13: 1091–9.
  • Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study | Diabetes Care | American Diabetes Association. https://diabetesjournals.org/care/article/45/10/2224/147469/Effects-of-Patient-Driven-Lifestyle-Modification (accessed March 6, 2023).
  • Cosson E, Hamo-Tchatchouang E, Dufaitre-Patouraux L, Attali J-R, Pariès J, Schaepelynck-Bélicar P. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients. Diabetes Metab 2009; 35: 312–8.
  • Cox DJ, Banton T, Moncrief M, et al. Glycemic excursion minimization in the management of type 2 diabetes: a novel intervention tested in a randomized clinical trial. BMJ Open Diabetes Res Care 2020; 8: e001795.
  • Furler J, O'Neal D, Speight J, et al. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol 2020; 8: 17–26.
  • Jospe MR, de Bruin WE, Haszard JJ, Mann JI, Brunton M, Taylor RW. Teaching people to eat according to appetite - Does the method of glucose measurement matter? Appetite 2020; 151: 104691.
  • Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007; 77: 174–9.
  • Meisenhelder-Smith J. The effects of American Diabetes Association (ADA) diabetes self-management education and continuous glucose monitoring on diabetes health beliefs, behaviors and metabolic control.
  • Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008; 337: a1680.
  • Price DA, Deng Q, Kipnes M, Beck SE. Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial. Diabetes Ther Res Treat Educ Diabetes Relat Disord 2021; 12: 2089–99.
  • Sato J, Kanazawa A, Ikeda F, et al. Effect of treatment guidance using a retrospective continuous glucose monitoring system on glycaemic control in outpatients with type 2 diabetes mellitus: A randomized controlled trial. J Int Med Res 2016; 44: 109–21.
  • Schembre SM, Jospe MR, Bedrick EJ, et al. Hunger Training as a Self-regulation Strategy in a Comprehensive Weight Loss Program for Breast Cancer Prevention: A Randomized Feasibility Study. Cancer Prev Res Phila Pa 2022; 15: 193–201.
  • Taylor PJ, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Wittert G, Brinkworth GD. Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study. Diabetes Ther Res Treat Educ Diabetes Relat Disord 2019; 10: 509–22.
  • Tildesley HD, Wright AM, Chan JHM, et al. A comparison of internet monitoring with continuous glucose monitoring in insulin-requiring type 2 diabetes mellitus. Can J Diabetes 2013; 37: 305–8.
  • Tumminia A, Milluzzo A, Festa C, et al. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study. Nutr Metab Cardiovasc Dis NMCD 2021; 31: 1851–9.
  • Voormolen DN, DeVries JH, Sanson RME, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial. Diabetes Obes Metab 2018; 20: 1894–902.
  • Wada E, Onoue T, Kobayashi T, et al. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 2020; 8: e001115.
  • Yan R-N, Cai T-T, Jiang L-L, et al. Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy. Front Endocrinol 2022; 13: 832102.
  • Yeoh E, Lim BK, Fun S, et al. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients. Nephrol Carlton Vic 2018; 23: 264–8.
  • Yoo HJ, An HG, Park SY, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2008; 82: 73–9.
  • Zhang X, Jiang D, Wang X. The effects of the instantaneous scanning glucose monitoring system on hypoglycemia, weight gain, and health behaviors in patients with gestational diabetes: a randomised trial. Ann Palliat Med 2021; 10: 5714–20.
  • Zhang W, Liu Y, Sun B, et al. Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring. Sci Rep 2021; 11: 23950.